Mitogenic effect of retinoid X receptor agonists in rat liver

Biochemical Pharmacology

Volumn 54, Issue 4, 1997, Pages 517-524

  Standeven, Andrew M ^a,b   Escobar, Maria ^a   Beard, Richard L ^a   Yuan, Yang Dar ^b   Chandraratna, Roshantha A S ^a  

^a Department of Biology ^*  (United States)

^b ALLERGAN INC   (United States)

Author keywords

Hepatomegaly; Liver; Mitogenesis; RAR; Retinoid; RXR

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; 4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1,3 DIOXOLAN 2 YL]BENZOIC ACID; AGN 191659; AGN 191701; BROXURIDINE; CLOFIBRATE; RETINOID; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEPATOMEGALY; INTRAGASTRIC DRUG ADMINISTRATION; LIVER; LIVER HYPERPLASIA; MALE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATOMEGALY; HYPERPLASIA; LIVER; MALE; MITOGENS; RATS; RATS, INBRED F344; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; THIOPHENES; TRANSCRIPTION FACTORS;

EID: 0030921519     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00209-8     Document Type: Article

References (38)

1. Mangelsdorf DJ, Umesono K and Evans RM, The retinoid receptors. In: The Retinoids: Biology, Chemistry, and Medicine (Eds. Sporn MB, Roberts AB and Goodman DS), pp. 319-349. Raven Press, New York, 1994.
2. Gendimenico GJ, Stim TB, Corbo M, Janssen B and Mezick JA, A pleiotropic response is induced in F9 embryonal carcinoma cells and rhino mouse skin by all-trans-retinoic acid, a RAR agonist but not by SR11237, a RXR-selective agonist. J Invest Dermatol 102: 676-680, 1994.
3. Valcarcel R, Holz H, Jimenez CG, Barettino D and Stunnenberg HG, Retinoid-dependent in vitro transcription mediated the RXR/RAR heterodimer. Genes Dev 8: 3068-3079, 1994.
4. Kliewer SA, Umesono K, Noonan DJ, Heyman RA and Evans RM, Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358: 771-774, 1992.
5. Issemann I, Prince RA, Tugwood JD and Green S, The retinoid X receptor enhances the function of the peroxisome proliferator activated receptor. Biochimie 75: 251-256, 1993.
6. Gearing KL, Gotlicher M, Teboul M, Widmark E and Gustafsson J-A, Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc Natl Acad Sci USA 90: 1440-1444, 1993.
7. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K and Wahli W, Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci USA 90: 2160-2164, 1993.
8. Kurokawa R, DiRenzo J, Boehm M, Sugarman J, Gloss B, Rosenfeld MG, Heyman RA and Glass CK, Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 371: 528-531, 1994.
9. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM and Thaller C, 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68: 397-406, 1992.
10. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen C, Rosenberger M, Lovey A and Grippo JF, 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 355: 359-361, 1992.
11. Yang YL, Vacchio MS and Ashwell JD, 9-cis-Retinoic acid inhibits activation-driven T-cell apoptosis: Implications for retinoid X receptor involvement in thymocyte development. Proc Natl Acad Sci USA 90: 6170-6174, 1993.
12. Anzano MA, Byers SW, Smith JM, Peer CW, Mullen LT, Brown CC, Roberts AB and Sporn MB, Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. Cancer Res 54: 4614-4617, 1994.
13. Lehmann JM, Jong L, Fanjul A, Cameron JF, Lu XP, Haefner P, Dawson MI and Pfahl M, Retinoids selective for retinoid X receptor response pathways. Science 258: 1944-1946, 1992.
14. Beard RL, Gil DW, Marier DK, Henry E, Colon DF, Gillett SJ, Arefieg T, Breen TS, Krauss H, Davies PJA and Chandraratna RAS, Structural basis for the differential RXR & RAR activity of stilbene retinoid analogs. Bioorg Med Chem Lett 4: 1447-1452, 1994.
15. Boehm MF, Zhang L, Badea BA, White SK, Mais DE, Berger E, Suto CM, Goldman ME and Heyman RA, Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. J Med Chem 37: 2930-2941, 1994.
16. Beard RL, Chandraratna RAS, Colon DF, Gillett SJ, Henry E, Marler DK, Song T, Denys L, Garst ME, Arefieg T, Klein E, Gil DW, Wheeler L, Kochhar DM and Davies PJA, Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids. J Med Chem 38: 2820-2829, 1995.
17. Nagy L, Thomazy VA, Shipley GL, Fesus L, Lamph W, Heyman RA, Chandraratna RAS and Davies PJA, Activation of retinoid X receptors (RXR) induces apoptosis in HL-60 cell lines. Mol Cell Biol 15: 3549-3551, 1995.
18. Jiang H, Penner JD, Beard RL, Chandraratna RAS and Kochhar DM, Diminished teratogenicity of retinoid X receptor-selective synthetic retinoids. Biochem Pharmacol 50: 669-676, 1995.
19. 3. J Biol Chem 270: 23906-23909, 1995.
20. Standeven AM, Beard RL, Johnson AT, Boehm AT, Escobar M, Heyman RA and Chandraratna RAS, Retinoid-induced hypertriglyceridemia in rats is mediated by retinoic acid receptors. Fundam Appl Toxicol 33: 264-271, 1996.
21. Popp JA and Cattley RC, Hepatobiliary system. In Handbook of Toxicologic Pathology (Eds. Haschek WM and Rousseaux CG), pp. 279-314. Academic Press, San Diego, 1991.
22. Loeliger P, Bollag W and Mayer H, Arotinoids, a new class of highly active retinoids. Eur J Med Chem 15: 9-15, 1980.
23. Standeven AM and Goldsworthy TL, Promotion of preneoplastic lesions and induction of CYP2B by unleaded gasoline vapor in female B6C3F1 mouse liver. Carcinogenesis 14: 2137-2141, 1993.
24. Bieber LL and Markwell MAK, Peroxisomal and microsomal carnitine acetyltransferases. Methods Enyzmol 71: 351-358, 1981.
25. Poosch MS and Yamazaki RK, Determination of peroxisomal fatty acyl-CoA oxidase activity using a lauroyl-CoA-based fluorometric assay. Biochim Biophys Acta 884: 585-593, 1986.
26. Goldsworthy TL, Morgan KT, Popp JA and Butterworth BE, Guidelines for measuring chemically induced cell proliferation in specific rodent target organs. In: Chemically Induced Cell Proliferation: Implications for Risk Assessment (Eds. Butterworth BE and Slaga TJ), pp. 253-284. Wiley-Liss, New York, 1991.
27. Marsman DS, Cattley RC, Conway JG and Popp JA, Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylindo)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res 48: 6739-6744, 1988.
28. Tanaka K, Smith PF, Stromberg PC, Eydelloth RS, Herold EG, Grossman SJ, Frank JD, Hertzog PR, Soper KA and Keenan KP, Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate. Toxicol Appl Pharmacol 116: 71-77, 1992.
29. 1 mice and male F-344 rats. Fundam Appl Toxicol 22: 431-446, 1994.
30. Reddy JK and Lalwani ND, Carcinogenesis by hepatic peroxisome proliferators: Evaluations of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit Rev Toxicol 12: 1-58, 1983.
31. Tilbury L, Butterworth BE, Moss O and Goldsworthy TL, Hepatocyte proliferation in mice after inhalation exposure to unleaded gasoline vapor. J Toxicol Environ Health 38: 293-307, 1993.
32. Ohmura T, Columbano GL, Columbano A, Katyal SL, Locker J and Shinozuka H, 9-cis Retinoic acid is a direct hepatocyte mitogen in rats. Life Sci 58: 211-216, 1996.
33. Butterworth BE, Popp JA, Connolly RB and Goldsworthy TL, Chemically induced cell proliferation in carcinogenesis. IARC Sci Publ 116: 279-305, 1992.
34. Ledda-Columbano GM, Coni P, Simbula G, Zedda I and Columbano A, Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis. Environ Health Perfect 101 (Suppl 5): 163-168, 1993.
35. Hawkins JM, Jones WE, Bonner FW and Gibson GG, The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metab Rev 18: 441-515, 1987.
36. Lee SS-T, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H and Gonzalez FJ, Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15: 3012-3022, 1995.
37. Apfel CM, Kamber M, Klaus M, Mohr P, Keidel S and LeMotte PK, Enhancement of HL-60 differentiation by a new class of retinoids with selective activity on retinoid X receptor. J Biol Chem 270: 30765-30772, 1995.
38. Boehm MF, Heyman RA, Patel S, Stein RB and Nagpal S, Retinoids: Biological function and use in the treatment of dermatological diseases. Expert Opin Invest Drugs 4: 593-612, 1995.